Amicus Therapeutics Showcases Innovative Medicines for Rare Diseases at Bank of America 2024 Health Care Conference
Amicus Therapeutics, a global biotechnology company focused on discovering, developing, and delivering high-quality medicines for individuals with rare diseases, announced that its management team will be participating in a fireside chat at the Bank of America 2024 Health Care Conference in Las Vegas, NV. The session is scheduled for Wednesday, May 15, 2024, at 1:40 p.m. P.T. Those interested can access a live audio webcast of the presentation through the investors section of the Amicus Therapeutics corporate website at https://ir.amicusrx.com/events-and-presentations.
Amicus Therapeutics is listed on Nasdaq under the symbol FOLD and has a mission to advance and expand a pipeline of innovative medicines for rare diseases with a strong emphasis on meeting the needs of patients. To learn more about Amicus Therapeutics and its work, visit the company’s website at www.amicusrx.com and follow them on X and LinkedIn. For investor inquiries, please contact Andrew Faughnan, Vice President of Investor Relations, at afaughnan@amicusrx.com or (609) 662-3809. For media inquiries, reach out to Diana Moore, Head of Global Corporate Affairs and Communications, at dmoore@amicusrx.com or (609) 662-5079.
